CP
ATOS icon

Castleview Partners’s Atossa Therapeutics ATOS Stock Holding History

Castleview Partners’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33
Closed -$440 – 906
2023
Q4 		$440 Hold
33
– – ﹤0.01% 808
2023
Q3 		$368 Hold
33
– – ﹤0.01% 648
2023
Q2 		$630 Hold
33
– – ﹤0.01% 657
2023
Q1 		$362 Hold
33
– – ﹤0.01% 647
2022
Q4 		$264 Hold
33
– – ﹤0.01% 606
2022
Q3 		$0 Buy
33
+27
+450% +$392 ﹤0.01% 618
2022
Q2 		$110 Sell
6
-27
-82% -$425 ﹤0.01% 748
2022
Q1 		$0 Sell
33
-20
-38% -$406 ﹤0.01% 729
2021
Q4 		$500 Buy
+53
New +$1.94K ﹤0.01% 520
2021
Q2 		$3K Buy
+33
New +$1.75K ﹤0.01% 822

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return